This compound is a steroidal pharmaceutical intermediate characterized by a tetracyclic ring system and multiple chiral centers. Its primary significance lies in its use as a building block for the synthesis of specialized steroid derivatives.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 459789-97-0
(R)-4-((3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
(R)-4-((3R,5S,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid
active pharmaceutical ingredient
6,7-DIHYDROXY-3,4-DIHYDROISOQUINOLINE
pharmaceutical intermediate
(1R,2R)-(-)-1,2-CYCLOHEXANEDICARBOXYLIC ACID
Pharmaceutical intermediate for lurasidone
3-hydroxy-2,3-dimethylbutan-2-yl hydrogen (10-phenylanthracen-9-yl)boronate
synthetic intermediate for boron-containing compounds
1,1,1-Trifluoro-4-iodobutane
Pharmaceutical intermediate
3alpha-Hydroxy-7-oxo-5beta-cholan-24-oic acid methyl ester
bile acid intermediate for drug synthesis
7-Ketolithocholic acid
bile acid intermediate
ethyl (4R)-4-[(3R,5S,6R,8S,9S,10S,13R,14S,17R)-6-ethyl-3-hydroxy-10,13-dimethyl-7-oxo-1,2,3,4,5,6,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]pentanoate
PRZCLWHVOYRZJL-GAKWKJAJSA-N
CC[C@@H]1[C@@H]2C[C@@H](CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C1=O)CC[C@@H]4[C@H](C)CCC(=O)OCC)C)C)O
—